193:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
DiAGnOstiC issues:@0.076191:0.087639:0.250261:0.087639:0.250261:0.067474:0.076191:0.067474:0.012935:0.005174:0.013674:0.015522:0.013674:0.015522:0.009609:0.007761:0.005174:0.014413:0.005174:0.005174:0.009609:0.009609:0.011826:0.009609:0.009609
Glaucoma is often described as the thief of sight. prima-:@0.076190:0.103581:0.480942:0.103581:0.480942:0.087798:0.076190:0.087798:0.012881:0.002721:0.010024:0.008890:0.009480:0.009601:0.013879:0.010024:0.005201:0.002721:0.005564:0.005201:0.009601:0.004445:0.004823:0.009525:0.008920:0.005201:0.010054:0.009525:0.005564:0.009480:0.004248:0.002721:0.010009:0.009525:0.010054:0.005201:0.010024:0.005564:0.005201:0.004823:0.008920:0.009525:0.005201:0.004823:0.008920:0.002721:0.009525:0.004445:0.005201:0.009601:0.004445:0.005201:0.005564:0.002721:0.009873:0.008920:0.004823:0.003886:0.005201:0.008648:0.004248:0.002721:0.013879:0.010024:0.005020
ry open-angle glaucoma is seen most commonly in the :@0.076190:0.117735:0.485191:0.117735:0.485191:0.101953:0.076190:0.101953:0.004248:0.007801:0.005957:0.009601:0.010009:0.009525:0.008920:0.004717:0.010024:0.008920:0.009873:0.002721:0.009525:0.005957:0.009873:0.002721:0.010024:0.008890:0.009480:0.009601:0.013879:0.010024:0.005957:0.002721:0.005564:0.005957:0.005564:0.009525:0.009525:0.008920:0.005957:0.013879:0.009601:0.005564:0.004823:0.005957:0.009480:0.009601:0.013879:0.013879:0.009601:0.008920:0.002721:0.007801:0.005957:0.002721:0.008920:0.005957:0.004823:0.008920:0.009827:0.004188
south African population and is asymptomatic. Using :@0.076190:0.131890:0.485175:0.131890:0.485175:0.116108:0.076190:0.116108:0.007227:0.009601:0.008890:0.004823:0.008920:0.009419:0.010886:0.004445:0.004248:0.002721:0.009480:0.010024:0.008920:0.009419:0.010009:0.009601:0.010009:0.008890:0.002721:0.010024:0.004823:0.002721:0.009601:0.008920:0.009419:0.010024:0.008920:0.010054:0.009419:0.002721:0.005564:0.009419:0.010024:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.010024:0.004823:0.002721:0.009480:0.003886:0.009419:0.009601:0.005564:0.002721:0.008920:0.010175:0.004188
tools, such as the glaucoma quality of life questionnaire; :@0.076190:0.146045:0.485115:0.146045:0.485115:0.130262:0.076190:0.130262:0.004823:0.009601:0.009601:0.002721:0.005564:0.003886:0.005277:0.005564:0.008890:0.009480:0.008920:0.005277:0.010024:0.005564:0.005277:0.004823:0.008920:0.009525:0.005277:0.009873:0.002721:0.010024:0.008890:0.009480:0.009601:0.013879:0.010024:0.005277:0.010009:0.008890:0.010024:0.002721:0.002721:0.004823:0.007801:0.005277:0.009601:0.004445:0.005277:0.002721:0.002721:0.004445:0.009525:0.005277:0.010009:0.008890:0.009525:0.005564:0.004823:0.002721:0.009601:0.008920:0.008920:0.010024:0.002721:0.004248:0.009525:0.004188:0.004188
taking a detailed family history; and screening for glau-:@0.076190:0.160200:0.480897:0.160200:0.480897:0.144417:0.076190:0.144417:0.004823:0.010024:0.007287:0.002721:0.008920:0.009873:0.006229:0.010024:0.006229:0.010054:0.009525:0.004823:0.010024:0.002721:0.002721:0.009525:0.010054:0.006229:0.004445:0.010024:0.013879:0.002721:0.002721:0.007801:0.006229:0.008920:0.002721:0.005564:0.004823:0.009601:0.004248:0.007801:0.003886:0.006229:0.010024:0.008920:0.010054:0.006229:0.005564:0.009480:0.004248:0.009525:0.009525:0.008920:0.002721:0.008920:0.009873:0.006229:0.004445:0.009601:0.004248:0.006229:0.009873:0.002721:0.010024:0.008890:0.005020
coma, while examining other conditions, such as diabetes :@0.076190:0.174354:0.485145:0.174354:0.485145:0.158572:0.076190:0.158572:0.009480:0.009601:0.013879:0.010024:0.003886:0.003402:0.012262:0.008920:0.002721:0.002721:0.009525:0.003402:0.009525:0.006955:0.010024:0.013879:0.002721:0.008920:0.002721:0.008920:0.009873:0.003402:0.009601:0.004823:0.008920:0.009525:0.004248:0.003402:0.009480:0.009601:0.008920:0.010054:0.002721:0.004823:0.002721:0.009601:0.008920:0.005564:0.003886:0.003402:0.005564:0.008890:0.009480:0.008920:0.003402:0.010024:0.005564:0.003402:0.010054:0.002721:0.010024:0.010009:0.009525:0.004823:0.009525:0.005866:0.004188
and hypertension, should be the mainstay of detection :@0.076190:0.188509:0.485160:0.188509:0.485160:0.172726:0.076190:0.172726:0.010024:0.008920:0.010054:0.006456:0.008920:0.007801:0.010009:0.009525:0.004248:0.004823:0.009525:0.008920:0.005564:0.002721:0.009601:0.008920:0.003886:0.006456:0.005564:0.008920:0.009601:0.008890:0.002721:0.010054:0.006456:0.010009:0.009525:0.006456:0.004823:0.008920:0.009525:0.006456:0.013879:0.010024:0.002721:0.008920:0.005564:0.004823:0.010024:0.007801:0.006456:0.009601:0.004445:0.006456:0.010054:0.009525:0.004823:0.009525:0.009480:0.004823:0.002721:0.009601:0.009223:0.004188
and appropriate referral and treatment of glaucoma. :@0.076190:0.202664:0.459231:0.202664:0.459231:0.186881:0.076190:0.186881:0.010024:0.008920:0.010054:0.003886:0.010024:0.010009:0.010009:0.004248:0.009601:0.010009:0.004248:0.002721:0.010024:0.004823:0.009525:0.003886:0.004248:0.009525:0.004445:0.009525:0.004248:0.004248:0.010024:0.002721:0.003886:0.010024:0.008920:0.010054:0.003886:0.004823:0.004248:0.009525:0.010024:0.004823:0.013879:0.009525:0.008920:0.004823:0.003886:0.009601:0.004445:0.003886:0.009873:0.002721:0.010024:0.008890:0.009480:0.009601:0.013879:0.010024:0.004188:0.004188
Appropriate parameters for which to screen are::@0.090478:0.216819:0.445942:0.216819:0.445942:0.201036:0.090478:0.201036:0.011188:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.004188:0.010311:0.010326:0.004551:0.010326:0.014182:0.009827:0.005125:0.009827:0.004551:0.005866:0.004188:0.004747:0.009903:0.004551:0.004188:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188:0.005125:0.009903:0.004188:0.005866:0.009782:0.004551:0.009827:0.009827:0.009223:0.004188:0.010326:0.004551:0.009827:0.004188
2,7:@0.445892:0.211559:0.458037:0.211559:0.458037:0.202405:0.445892:0.202405:0.004858:0.002429:0.004858
•  Testing the pupillary reaction to direct light, the con:@0.076191:0.231017:0.475908:0.231017:0.475908:0.215234:0.076191:0.215234:0.009162:0.004188:0.006804:0.006441:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004566:0.005125:0.009223:0.009827:0.004566:0.010311:0.009192:0.010311:0.003024:0.003024:0.003024:0.010326:0.004551:0.008104:0.004581:0.004551:0.009827:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004566:0.005125:0.009903:0.004566:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.004566:0.003024:0.003024:0.010175:0.009223:0.005125:0.004188:0.004566:0.005125:0.009223:0.009827:0.004566:0.009782:0.009903:0.009223
-:@0.475908:0.231017:0.480927:0.231017:0.480927:0.215234:0.475908:0.215234:0.005020
sensual response to light and the pupil constriction to :@0.096344:0.245172:0.485130:0.245172:0.485130:0.229389:0.096344:0.229389:0.005866:0.009827:0.009223:0.005866:0.009192:0.010326:0.003024:0.003855:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.005866:0.009827:0.003840:0.005125:0.009903:0.003840:0.003024:0.003024:0.010175:0.009223:0.005125:0.003855:0.010326:0.009223:0.010357:0.003855:0.005125:0.009223:0.009827:0.003855:0.010311:0.009192:0.010311:0.003024:0.003024:0.003855:0.009782:0.009903:0.009223:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.003024:0.009903:0.009223:0.003840:0.005125:0.009903:0.004188
accommodation.:@0.096344:0.259327:0.226549:0.259327:0.226549:0.243544:0.096344:0.243544:0.010326:0.009782:0.009782:0.009903:0.014182:0.014182:0.009903:0.010357:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
•  Testing for decreased visual acuity, using a near and :@0.076191:0.273481:0.485145:0.273481:0.485145:0.257699:0.076191:0.257699:0.009162:0.004188:0.006804:0.006441:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004218:0.004747:0.009903:0.004551:0.004218:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004218:0.008376:0.003024:0.005866:0.009192:0.010341:0.003024:0.004233:0.010326:0.009782:0.009192:0.003024:0.005125:0.008104:0.004188:0.004233:0.009192:0.005866:0.003024:0.009223:0.010175:0.004233:0.010326:0.004233:0.009223:0.009827:0.010326:0.004551:0.004218:0.010326:0.009223:0.010357:0.004188
distant reading card, and to confirm that the visual :@0.096344:0.287636:0.485115:0.287636:0.485115:0.271853:0.096344:0.271853:0.010357:0.003024:0.005866:0.005125:0.010326:0.009223:0.005125:0.005655:0.004551:0.009827:0.010326:0.010357:0.003024:0.009223:0.010175:0.005639:0.009782:0.010326:0.004551:0.010357:0.004188:0.005639:0.010326:0.009223:0.010357:0.005639:0.005125:0.009903:0.005639:0.009782:0.009903:0.009223:0.003681:0.003681:0.004551:0.014182:0.005639:0.005125:0.009223:0.010326:0.005125:0.005639:0.005125:0.009223:0.009827:0.005639:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.004188
loss is not due to a refractive error, by using a pinhole :@0.096344:0.301791:0.485130:0.301791:0.485130:0.286008:0.096344:0.286008:0.003024:0.009903:0.005866:0.005866:0.003976:0.003024:0.005866:0.003976:0.009223:0.009903:0.005125:0.003961:0.010357:0.009192:0.009827:0.003961:0.005125:0.009903:0.003961:0.010326:0.003961:0.004551:0.009827:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.003961:0.009827:0.004551:0.004551:0.009903:0.004551:0.004188:0.003946:0.010311:0.008104:0.003976:0.009192:0.005866:0.003024:0.009223:0.010175:0.003961:0.010326:0.003961:0.010311:0.003024:0.009223:0.009223:0.009903:0.003024:0.009827:0.004188
to identify this. The visual acuity must be tested with :@0.096344:0.315945:0.485145:0.315945:0.485145:0.300163:0.096344:0.300163:0.005125:0.009903:0.005246:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.004747:0.008104:0.005261:0.005125:0.009223:0.003024:0.005866:0.004188:0.005261:0.006441:0.009223:0.009827:0.005246:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.005261:0.010326:0.009782:0.009192:0.003024:0.005125:0.008104:0.005261:0.014182:0.009192:0.005866:0.005125:0.005261:0.010311:0.009827:0.005261:0.005125:0.009827:0.005866:0.005125:0.009827:0.010357:0.005246:0.012564:0.003024:0.005125:0.009223:0.004188
the correct refraction in place.:@0.096344:0.330100:0.321557:0.330100:0.321557:0.314318:0.096344:0.314318:0.005125:0.009223:0.009827:0.004188:0.009782:0.009903:0.004551:0.004551:0.009827:0.009782:0.005125:0.004188:0.004551:0.009827:0.004747:0.004551:0.010326:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003024:0.009223:0.004188:0.010311:0.003024:0.010326:0.009782:0.009827:0.004188
•  Measuring  raised  intra-ocular  pressure  (IOP)  by  us:@0.076191:0.344255:0.475908:0.344255:0.475908:0.328472:0.076191:0.328472:0.009162:0.004188:0.006804:0.013894:0.009827:0.010326:0.005866:0.009192:0.004551:0.003024:0.009223:0.010175:0.004188:0.003372:0.004551:0.010326:0.003024:0.005866:0.009827:0.010357:0.004188:0.003387:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020:0.009903:0.009782:0.009177:0.003024:0.010326:0.004551:0.004188:0.003372:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.003372:0.005579:0.003417:0.013138:0.008950:0.005579:0.004188:0.003372:0.010311:0.008104:0.004188:0.003372:0.009192:0.005866
-:@0.475908:0.344255:0.480927:0.344255:0.480927:0.328472:0.475908:0.328472:0.005020
ing a hand-held applanation tonometer, i care to-:@0.096344:0.358410:0.480957:0.358410:0.480957:0.342627:0.096344:0.342627:0.003024:0.009223:0.010175:0.006395:0.010326:0.006395:0.009223:0.010326:0.009223:0.010357:0.005020:0.009223:0.009827:0.003024:0.010357:0.006395:0.010326:0.010311:0.010311:0.003024:0.010326:0.009223:0.010326:0.005125:0.003024:0.009903:0.009223:0.006395:0.005125:0.009903:0.009223:0.009903:0.014182:0.009827:0.005125:0.009827:0.004551:0.004188:0.006380:0.003024:0.006395:0.009782:0.010326:0.004551:0.009827:0.006395:0.005125:0.009903:0.005020
nometer or a schiotz tonometer. The normal range of :@0.096344:0.372564:0.485145:0.372564:0.485145:0.356782:0.096344:0.356782:0.009223:0.009903:0.014182:0.009827:0.005125:0.009827:0.004551:0.003598:0.009903:0.004551:0.003613:0.010326:0.003613:0.007529:0.009782:0.009223:0.003024:0.009903:0.005125:0.006426:0.003613:0.005125:0.009903:0.009223:0.009903:0.014182:0.009827:0.005125:0.009827:0.004551:0.004188:0.003598:0.006441:0.009223:0.009827:0.003613:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003613:0.004551:0.010326:0.009223:0.010175:0.009827:0.003613:0.009903:0.004747:0.004188
IOp is 8-22 mmHg, although women have a naturally :@0.096344:0.386719:0.485130:0.386719:0.485130:0.370936:0.096344:0.370936:0.003417:0.013138:0.008950:0.004264:0.003024:0.005866:0.004279:0.008376:0.005020:0.008376:0.008376:0.004279:0.014182:0.014182:0.010326:0.010175:0.004188:0.004264:0.010326:0.003024:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.004264:0.012564:0.009903:0.014182:0.009827:0.009223:0.004264:0.009223:0.010326:0.008376:0.009827:0.004264:0.010326:0.004264:0.009223:0.010326:0.005125:0.009192:0.004551:0.010326:0.003024:0.003024:0.008104:0.004188
higher intra-ocular pressure.:@0.096344:0.400874:0.298970:0.400874:0.298970:0.385091:0.096344:0.385091:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004188:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.004188:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188
•  Testing for confrontation visual fields will also show a :@0.076191:0.415028:0.485130:0.415028:0.485130:0.399246:0.076191:0.399246:0.009162:0.004188:0.006804:0.006441:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.005095:0.004747:0.009903:0.004551:0.005095:0.009782:0.009903:0.009223:0.004747:0.004551:0.009903:0.009223:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005080:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.005110:0.003681:0.003681:0.009827:0.003024:0.010357:0.005866:0.005095:0.012564:0.003024:0.003024:0.003024:0.005110:0.010326:0.003024:0.005866:0.009903:0.005095:0.005866:0.009223:0.009903:0.012564:0.005095:0.010326:0.004188
constricted visual field in advanced glaucoma. For:@0.096344:0.429183:0.475908:0.429183:0.475908:0.413401:0.096344:0.413401:0.009782:0.009903:0.009223:0.005866:0.005125:0.004551:0.003024:0.009782:0.005125:0.009827:0.010357:0.005473:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.005488:0.003681:0.003681:0.009827:0.003024:0.010357:0.005488:0.003024:0.009223:0.005488:0.010326:0.010357:0.008376:0.010326:0.009223:0.009782:0.009827:0.010357:0.005488:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.005488:0.007333:0.009903:0.004551
-:@0.475923:0.429183:0.480942:0.429183:0.480942:0.413401:0.475923:0.413401:0.005020
mal visual field-testing is done, using manual or auto:@0.096344:0.443338:0.475923:0.443338:0.475923:0.427555:0.096344:0.427555:0.014182:0.010326:0.003024:0.004143:0.008376:0.003024:0.005866:0.009192:0.010326:0.003024:0.004158:0.003681:0.003681:0.009827:0.003024:0.010357:0.005020:0.005125:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.004143:0.003024:0.005866:0.004143:0.010357:0.009903:0.009223:0.009827:0.004188:0.004127:0.009192:0.005866:0.003024:0.009223:0.010175:0.004143:0.014182:0.010326:0.009223:0.009192:0.010326:0.003024:0.004143:0.009903:0.004551:0.004143:0.010326:0.009192:0.005125:0.009903
-:@0.475923:0.443338:0.480942:0.443338:0.480942:0.427555:0.475923:0.427555:0.005020
mated perimetry.:@0.096344:0.457493:0.224040:0.457493:0.224040:0.441710:0.096344:0.441710:0.014182:0.010326:0.005125:0.009827:0.010357:0.004188:0.010311:0.009827:0.004551:0.003024:0.014182:0.009827:0.005125:0.004551:0.008104:0.004188
•  Doing  a  disc  assessment  with  a  direct  ophthalmo:@0.076191:0.471647:0.475908:0.471647:0.475908:0.455865:0.076191:0.455865:0.009162:0.004188:0.006804:0.011249:0.009903:0.003024:0.009223:0.010175:0.004188:0.003024:0.010326:0.004188:0.003024:0.010357:0.003024:0.005866:0.009782:0.004188:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.014182:0.009827:0.009223:0.005125:0.004188:0.003039:0.012564:0.003024:0.005125:0.009223:0.004188:0.003024:0.010326:0.004188:0.003039:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.004188:0.003024:0.009903:0.010311:0.009223:0.005125:0.009223:0.010326:0.003024:0.014182:0.009903
-:@0.475908:0.471647:0.480927:0.471647:0.480927:0.455865:0.475908:0.455865:0.005020
scope, fundus camera or smartphone. Indirect oph-:@0.096344:0.485802:0.480927:0.485802:0.480927:0.470019:0.096344:0.470019:0.005866:0.009782:0.009903:0.010311:0.009827:0.004188:0.005035:0.004747:0.009192:0.009223:0.010357:0.009192:0.005866:0.005035:0.009782:0.010326:0.014182:0.009827:0.004551:0.010326:0.005035:0.009903:0.004551:0.005035:0.005866:0.014182:0.010326:0.004551:0.005125:0.010311:0.009223:0.009903:0.009223:0.009827:0.004188:0.005020:0.003417:0.009223:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.005035:0.009903:0.010311:0.009223:0.005020
thalmoscopy is also an important aspect of assess-:@0.096344:0.499957:0.480942:0.499957:0.480942:0.484174:0.096344:0.484174:0.005125:0.009223:0.010326:0.003024:0.014182:0.009903:0.005866:0.009782:0.009903:0.010311:0.008104:0.006426:0.003024:0.005866:0.006426:0.010326:0.003024:0.005866:0.009903:0.006426:0.010326:0.009223:0.006426:0.003024:0.014182:0.010311:0.009903:0.004551:0.005125:0.010326:0.009223:0.005125:0.006410:0.010326:0.005866:0.010311:0.009827:0.009782:0.005125:0.006426:0.009903:0.004747:0.006426:0.010326:0.005866:0.005866:0.009827:0.005866:0.005896:0.005020
ment in glaucoma. The disc assessment must include:@0.096344:0.514111:0.480942:0.514111:0.480942:0.498329:0.096344:0.498329:0.014182:0.009827:0.009223:0.005125:0.003946:0.003024:0.009223:0.003946:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.003946:0.006441:0.009223:0.009827:0.003931:0.010357:0.003024:0.005866:0.009782:0.003946:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.014182:0.009827:0.009223:0.005125:0.003946:0.014182:0.009192:0.005866:0.005125:0.003946:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827
-  Cup-disc ratio (more than 0,6):@0.096344:0.528266:0.336480:0.528266:0.336480:0.512484:0.096344:0.512484:0.005020:0.004188:0.010946:0.012292:0.009192:0.010311:0.005020:0.010357:0.003024:0.005866:0.009782:0.004188:0.004551:0.010326:0.005125:0.003024:0.009903:0.004188:0.005579:0.014182:0.009903:0.004551:0.009827:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.008376:0.004188:0.008376:0.005579
-  Notching:@0.096344:0.542421:0.184140:0.542421:0.184140:0.526638:0.096344:0.526638:0.005020:0.004188:0.010946:0.011188:0.009903:0.005125:0.009782:0.009223:0.003024:0.009223:0.010175
-  Loss of retinal nerve-fibre layer:@0.096344:0.556576:0.336329:0.556576:0.336329:0.540793:0.096344:0.540793:0.005020:0.004188:0.010946:0.006985:0.009903:0.005866:0.005866:0.004188:0.009903:0.004747:0.004188:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188:0.009223:0.009827:0.004551:0.008376:0.009827:0.005020:0.003681:0.003681:0.010311:0.004551:0.009827:0.004188:0.003024:0.010326:0.008104:0.009827:0.004551
-  Optic disc haemorrhage:@0.096344:0.570730:0.297397:0.570730:0.297397:0.554948:0.096344:0.554948:0.005020:0.004188:0.010946:0.013138:0.010311:0.005125:0.003024:0.009782:0.004188:0.010357:0.003024:0.005866:0.009782:0.004188:0.009223:0.010326:0.009827:0.014182:0.009903:0.004551:0.004551:0.009223:0.010326:0.010175:0.009827
-  Bayonetting of blood vessels:@0.096344:0.584885:0.324596:0.584885:0.324596:0.569102:0.096344:0.569102:0.005020:0.004188:0.010946:0.008678:0.010326:0.008104:0.009903:0.009223:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.004188:0.009903:0.004747:0.004188:0.010311:0.003024:0.009903:0.009903:0.010357:0.004188:0.008376:0.009827:0.005866:0.005866:0.009827:0.003024:0.005866
-  Laminar dot sign of exposed cribriform plate:@0.096344:0.599040:0.439153:0.599040:0.439153:0.583257:0.096344:0.583257:0.005020:0.004188:0.010946:0.006985:0.010326:0.014182:0.003024:0.009223:0.010326:0.004551:0.004188:0.010357:0.009903:0.005125:0.004188:0.005866:0.003024:0.010175:0.009223:0.004188:0.009903:0.004747:0.004188:0.009827:0.007257:0.010311:0.009903:0.005866:0.009827:0.010357:0.004188:0.009782:0.004551:0.003024:0.010311:0.004551:0.003024:0.004747:0.009903:0.004551:0.014182:0.004188:0.010311:0.003024:0.010326:0.005125:0.009827
-  Nasalisation of blood vessels:@0.096344:0.613195:0.323084:0.613195:0.323084:0.597412:0.096344:0.597412:0.005020:0.004188:0.010946:0.011188:0.010326:0.005866:0.010326:0.003024:0.003024:0.005866:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.010311:0.003024:0.009903:0.009903:0.010357:0.004188:0.008376:0.009827:0.005866:0.005866:0.009827:0.003024:0.005866
-  peripapillary atrophy:@0.096344:0.627349:0.267582:0.627349:0.267582:0.611567:0.096344:0.611567:0.005020:0.004188:0.010946:0.008950:0.009827:0.004551:0.003024:0.010311:0.010326:0.010311:0.003024:0.003024:0.003024:0.010326:0.004551:0.008104:0.004188:0.010326:0.005125:0.004551:0.009903:0.010311:0.009223:0.008104
-  IsNT rule not followed on the disc (the order of the :@0.096344:0.641504:0.485145:0.641504:0.485145:0.625721:0.096344:0.625721:0.005020:0.004188:0.010946:0.003417:0.007529:0.011188:0.006441:0.004158:0.004551:0.009192:0.003024:0.009827:0.004158:0.009223:0.009903:0.005125:0.004158:0.004747:0.009903:0.003024:0.003024:0.009903:0.012564:0.009827:0.010357:0.004158:0.009903:0.009223:0.004158:0.005125:0.009223:0.009827:0.004158:0.010357:0.003024:0.005866:0.009782:0.004173:0.005579:0.005125:0.009223:0.009827:0.004158:0.009903:0.004551:0.010357:0.009827:0.004551:0.004158:0.009903:0.004747:0.004158:0.005125:0.009223:0.009827:0.004188
thickest to the thinnest part of the optic disc):@0.116498:0.655659:0.443296:0.655659:0.443296:0.639876:0.116498:0.639876:0.005125:0.009223:0.003024:0.009782:0.007590:0.009827:0.005866:0.005125:0.004188:0.005125:0.009903:0.004188:0.005125:0.009223:0.009827:0.004188:0.005125:0.009223:0.003024:0.009223:0.009223:0.009827:0.005866:0.005125:0.004188:0.010311:0.010326:0.004551:0.005125:0.004188:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.009903:0.010311:0.005125:0.003024:0.009782:0.004188:0.010357:0.003024:0.005866:0.009782:0.005579
The disc assessment can also be done using an optic :@0.090463:0.669813:0.485145:0.669813:0.485145:0.654031:0.090463:0.654031:0.006441:0.009223:0.009827:0.004536:0.010357:0.003024:0.005866:0.009782:0.004551:0.010326:0.005866:0.005866:0.009827:0.005866:0.005866:0.014182:0.009827:0.009223:0.005125:0.004551:0.009782:0.010326:0.009223:0.004551:0.010326:0.003024:0.005866:0.009903:0.004551:0.010311:0.009827:0.004551:0.010357:0.009903:0.009223:0.009827:0.004536:0.009192:0.005866:0.003024:0.009223:0.010175:0.004551:0.010326:0.009223:0.004551:0.009903:0.010311:0.005125:0.003024:0.009782:0.004188
nerve head OCT (optical coherence  tomography)  in :@0.076175:0.683968:0.485115:0.683968:0.485115:0.668185:0.076175:0.668185:0.009223:0.009827:0.004551:0.008376:0.009827:0.007121:0.009223:0.009827:0.010326:0.010357:0.007121:0.013138:0.012292:0.006441:0.007121:0.005579:0.009903:0.010311:0.005125:0.003024:0.009782:0.010326:0.003024:0.007121:0.009782:0.009903:0.009223:0.009827:0.004551:0.009827:0.009223:0.009782:0.009827:0.004188:0.002918:0.005125:0.009903:0.014182:0.009903:0.010175:0.004551:0.010326:0.010311:0.009223:0.008104:0.005579:0.004188:0.002918:0.003024:0.009223:0.004188
conjunction  with  colour  fundus  photographs  and nor-:@0.076175:0.698123:0.480942:0.698123:0.480942:0.682340:0.076175:0.682340:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.002298:0.012564:0.003024:0.005125:0.009223:0.004188:0.002298:0.009782:0.009903:0.003024:0.009903:0.009192:0.004551:0.004188:0.002298:0.004747:0.009192:0.009223:0.010357:0.009192:0.005866:0.004188:0.002298:0.010311:0.009223:0.009903:0.005125:0.009903:0.010175:0.004551:0.010326:0.010311:0.009223:0.005866:0.004188:0.002298:0.010326:0.009223:0.010357:0.006501:0.009223:0.009903:0.004551:0.005020
mative data for analysis.:@0.076175:0.712278:0.254882:0.712278:0.254882:0.696495:0.076175:0.696495:0.014182:0.010326:0.005125:0.003024:0.008376:0.009827:0.004188:0.010357:0.010326:0.005125:0.010326:0.004188:0.004747:0.009903:0.004551:0.004188:0.010326:0.009223:0.010326:0.003024:0.008104:0.005866:0.003024:0.005866:0.004188
PAtHOPHysiOlOGy:@0.076191:0.745350:0.251370:0.745350:0.251370:0.725185:0.076191:0.725185:0.010348:0.013674:0.007761:0.012566:0.015522:0.010348:0.012566:0.011457:0.009609:0.005174:0.015522:0.008131:0.015522:0.015522:0.011457
Glaucoma is multifactorial, acting on cell bodies and :@0.076191:0.761288:0.485130:0.761288:0.485130:0.745505:0.076191:0.745505:0.013184:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.006395:0.003024:0.005866:0.006395:0.014182:0.009192:0.003024:0.005125:0.003024:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.003024:0.010326:0.003024:0.004188:0.006395:0.010326:0.009782:0.005125:0.003024:0.009223:0.010175:0.006395:0.009903:0.009223:0.006395:0.009782:0.009827:0.003024:0.003024:0.006395:0.010311:0.009903:0.010357:0.003024:0.009827:0.005866:0.006395:0.010326:0.009223:0.010357:0.004188
their axons and resulting in retinal ganglion cell death.:@0.076191:0.775443:0.471054:0.775443:0.471054:0.759660:0.076191:0.759660:0.005125:0.009223:0.009827:0.003024:0.004551:0.004188:0.010326:0.007257:0.009903:0.009223:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.003024:0.009223:0.010175:0.004188:0.003024:0.009223:0.004188:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188:0.010175:0.010326:0.009223:0.010175:0.003024:0.003024:0.009903:0.009223:0.004188:0.009782:0.009827:0.003024:0.003024:0.004188:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188
8:@0.471020:0.770149:0.475878:0.770149:0.475878:0.760995:0.471020:0.760995:0.004858
Factor 1: :@0.090476:0.789607:0.160644:0.789607:0.160644:0.773824:0.090476:0.773824:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.006395:0.008376:0.004188:0.004188
Apoptosis:@0.162851:0.789607:0.234818:0.789607:0.234818:0.773109:0.162851:0.773109:0.011188:0.009979:0.009676:0.009979:0.004536:0.009676:0.006652:0.003629:0.006652
 causing neuronal loss mediated :@0.234818:0.789607:0.485144:0.789607:0.485144:0.773824:0.234818:0.773824:0.006395:0.009782:0.010326:0.009192:0.005866:0.003024:0.009223:0.010175:0.006395:0.009223:0.009827:0.009192:0.004551:0.009903:0.009223:0.010326:0.003024:0.006395:0.003024:0.009903:0.005866:0.005866:0.006410:0.014182:0.009827:0.010357:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
by caspases (these  are  part  of  the  cysteine  aspartyl-:@0.076189:0.803762:0.480925:0.803762:0.480925:0.787979:0.076189:0.787979:0.010311:0.008104:0.006940:0.009782:0.010326:0.005866:0.010311:0.010326:0.005866:0.009827:0.005866:0.006940:0.005579:0.005125:0.009223:0.009827:0.005866:0.009827:0.004188:0.002737:0.010326:0.004551:0.009827:0.004188:0.002737:0.010311:0.010326:0.004551:0.005125:0.004188:0.002737:0.009903:0.004747:0.004188:0.002737:0.005125:0.009223:0.009827:0.004188:0.002737:0.009782:0.008104:0.005866:0.005125:0.009827:0.003024:0.009223:0.009827:0.004188:0.002737:0.010326:0.005866:0.010311:0.010326:0.004551:0.005125:0.008104:0.003024:0.005020
specific proteases). The caspases interact with TNF al:@0.076189:0.817916:0.475921:0.817916:0.475921:0.802134:0.076189:0.802134:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.006214:0.010311:0.004551:0.009903:0.005125:0.009827:0.010326:0.005866:0.009827:0.005866:0.005579:0.004188:0.006214:0.006441:0.009223:0.009827:0.006214:0.009782:0.010326:0.005866:0.010311:0.010326:0.005866:0.009827:0.005866:0.006229:0.003024:0.009223:0.005125:0.009827:0.004551:0.010326:0.009782:0.005125:0.006214:0.012564:0.003024:0.005125:0.009223:0.006214:0.006441:0.011188:0.007333:0.006214:0.010326:0.003024
-:@0.475921:0.817916:0.480940:0.817916:0.480940:0.802134:0.475921:0.802134:0.005020
pha (extrinsic) and mitochondrion (intrinsic).:@0.076189:0.832071:0.397151:0.832071:0.397151:0.816289:0.076189:0.816289:0.010311:0.009223:0.010326:0.004188:0.005579:0.009827:0.007257:0.005125:0.004551:0.003024:0.009223:0.005866:0.003024:0.009782:0.005579:0.004188:0.010326:0.009223:0.010357:0.004188:0.014182:0.003024:0.005125:0.009903:0.009782:0.009223:0.009903:0.009223:0.010357:0.004551:0.003024:0.009903:0.009223:0.004188:0.005579:0.003024:0.009223:0.005125:0.004551:0.003024:0.009223:0.005866:0.003024:0.009782:0.005579:0.004188
Factor 2: :@0.090476:0.846226:0.159827:0.846226:0.159827:0.830443:0.090476:0.830443:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.005579:0.008376:0.004188:0.004188
increased intra-ocular pressure:@0.161218:0.846226:0.392948:0.846226:0.392948:0.829727:0.161218:0.829727:0.004233:0.009071:0.009676:0.004838:0.009676:0.009979:0.006652:0.009676:0.009979:0.005655:0.003629:0.009071:0.004536:0.004838:0.009979:0.006350:0.009676:0.009676:0.009071:0.003629:0.009979:0.004838:0.005639:0.009979:0.004838:0.009676:0.006652:0.006652:0.009071:0.004838:0.009676
 results from :@0.392948:0.846226:0.485128:0.846226:0.485128:0.830443:0.392948:0.830443:0.005579:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.005866:0.005579:0.004747:0.004551:0.009903:0.014182:0.004188
changes in the trabecular meshwork (changes in cel-:@0.076189:0.860381:0.480940:0.860381:0.480940:0.844598:0.076189:0.844598:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.006184:0.003024:0.009223:0.006184:0.005125:0.009223:0.009827:0.006184:0.005125:0.004551:0.010326:0.010311:0.009827:0.009782:0.009192:0.003024:0.010326:0.004551:0.006184:0.014182:0.009827:0.005866:0.009223:0.012564:0.009903:0.004551:0.007590:0.006184:0.005579:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.005866:0.006184:0.003024:0.009223:0.006184:0.009782:0.009827:0.003024:0.005020
lularity and the extracellular matrix.) The increased pres-:@0.076189:0.874535:0.480925:0.874535:0.480925:0.858753:0.076189:0.858753:0.003024:0.009192:0.003024:0.010326:0.004551:0.003024:0.005125:0.008104:0.003780:0.010326:0.009223:0.010357:0.003765:0.005125:0.009223:0.009827:0.003765:0.009827:0.007257:0.005125:0.004551:0.010326:0.009782:0.009827:0.003024:0.003024:0.009192:0.003024:0.010326:0.004551:0.003765:0.014182:0.010326:0.005125:0.004551:0.003024:0.007257:0.004188:0.005579:0.003765:0.006441:0.009223:0.009827:0.003765:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.003765:0.010311:0.004551:0.009827:0.005866:0.005020
sure triggers apoptosis and a second, slower phase due :@0.076189:0.888690:0.485128:0.888690:0.485128:0.872907:0.076189:0.872907:0.005866:0.009192:0.004551:0.009827:0.003916:0.005125:0.004551:0.003024:0.010175:0.010175:0.009827:0.004551:0.005866:0.003916:0.010326:0.010311:0.009903:0.010311:0.005125:0.009903:0.005866:0.003024:0.005866:0.003931:0.010326:0.009223:0.010357:0.003916:0.010326:0.003916:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.004188:0.003916:0.005866:0.003024:0.009903:0.012564:0.009827:0.004551:0.003916:0.010311:0.009223:0.010326:0.005866:0.009827:0.003916:0.010357:0.009192:0.009827:0.004188
to toxic effects of the already degenerating neurons.:@0.076189:0.902845:0.464521:0.902845:0.464521:0.887062:0.076189:0.887062:0.005125:0.009903:0.004188:0.005125:0.009903:0.007257:0.003024:0.009782:0.004188:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004188:0.009903:0.004747:0.004188:0.005125:0.009223:0.009827:0.004188:0.010326:0.003024:0.004551:0.009827:0.010326:0.010357:0.008104:0.004188:0.010357:0.009827:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.005125:0.003024:0.009223:0.010175:0.004188:0.009223:0.009827:0.009192:0.004551:0.009903:0.009223:0.005866:0.004188
Factor  3: :@0.090476:0.917000:0.160810:0.917000:0.160810:0.901217:0.090476:0.901217:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.004188:0.002374:0.008376:0.004188:0.004188
molecular mechanisms:@0.163184:0.917000:0.336433:0.917000:0.336433:0.900501:0.163184:0.900501:0.013607:0.009676:0.003629:0.009676:0.009676:0.009071:0.003629:0.009979:0.004838:0.006637:0.014212:0.009676:0.009676:0.009071:0.009979:0.009071:0.003629:0.006652:0.014212:0.006652
  of  retinal  ganglion :@0.336433:0.917000:0.485128:0.917000:0.485128:0.901217:0.336433:0.901217:0.004188:0.002374:0.009903:0.004747:0.004188:0.002374:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188:0.002374:0.010175:0.010326:0.009223:0.010175:0.003024:0.003024:0.009903:0.009223:0.004188
cell apoptosis occur with remodelling of type i and iv :@0.076189:0.931154:0.485113:0.931154:0.485113:0.915372:0.076189:0.915372:0.009782:0.009827:0.003024:0.003024:0.006214:0.010326:0.010311:0.009903:0.010311:0.005125:0.009903:0.005866:0.003024:0.005866:0.006214:0.009903:0.009782:0.009782:0.009192:0.004551:0.006199:0.012564:0.003024:0.005125:0.009223:0.006199:0.004551:0.009827:0.014182:0.009903:0.010357:0.009827:0.003024:0.003024:0.003024:0.009223:0.010175:0.006199:0.009903:0.004747:0.006199:0.005125:0.008104:0.010311:0.009827:0.006199:0.003024:0.006214:0.010326:0.009223:0.010357:0.006199:0.003024:0.008376:0.004188
collagen, transforming growth factor b2 (TGF b2) and :@0.076189:0.945309:0.485128:0.945309:0.485128:0.929526:0.076189:0.929526:0.009782:0.009903:0.003024:0.003024:0.010326:0.010175:0.009827:0.009223:0.004188:0.006138:0.005125:0.004551:0.010326:0.009223:0.005866:0.004747:0.009903:0.004551:0.014182:0.003024:0.009223:0.010175:0.006138:0.010175:0.004551:0.009903:0.012564:0.005125:0.009207:0.006153:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.006138:0.010311:0.008376:0.006153:0.005579:0.006441:0.013184:0.007333:0.006153:0.010311:0.008376:0.005579:0.006153:0.010326:0.009223:0.010357:0.004188
matrix metalloproteinases (MMp) occurs. An increase in :@0.519040:0.084873:0.927965:0.084873:0.927965:0.069090:0.519040:0.069090:0.014182:0.010326:0.005125:0.004551:0.003024:0.007257:0.004127:0.014182:0.009827:0.005125:0.010326:0.003024:0.003024:0.009903:0.010311:0.004551:0.009903:0.005125:0.009827:0.003024:0.009223:0.010326:0.005866:0.009827:0.005866:0.004127:0.005579:0.013894:0.013894:0.008950:0.005579:0.004127:0.009903:0.009782:0.009782:0.009192:0.004551:0.005866:0.004188:0.004127:0.011188:0.009223:0.004127:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004127:0.003024:0.009223:0.004188
MMp and decreased laminin shows increase in retinal :@0.519040:0.099085:0.927995:0.099085:0.927995:0.083303:0.519040:0.083303:0.013894:0.013894:0.008950:0.006017:0.010326:0.009223:0.010357:0.006032:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.006017:0.003024:0.010326:0.014182:0.003024:0.009223:0.003024:0.009223:0.006032:0.005866:0.009223:0.009903:0.012564:0.005866:0.006032:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.006017:0.003024:0.009223:0.006032:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.004188
ganglion  cell death.  The  increased  MMps  upregulate :@0.519040:0.113298:0.927995:0.113298:0.927995:0.097515:0.519040:0.097515:0.010175:0.010326:0.009223:0.010175:0.003024:0.003024:0.009903:0.009223:0.004188:0.002903:0.009782:0.009827:0.003024:0.003024:0.007106:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188:0.004188:0.002903:0.006441:0.009223:0.009827:0.004188:0.002903:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188:0.002903:0.013894:0.013894:0.008950:0.005866:0.004188:0.002903:0.009192:0.010311:0.004551:0.009827:0.010175:0.009192:0.003024:0.010326:0.005125:0.009827:0.004188
glutamate  receptors.  A  decrease  in  growth  factors, :@0.519040:0.127510:0.927995:0.127510:0.927995:0.111728:0.519040:0.111728:0.010175:0.003024:0.009192:0.005125:0.010326:0.014182:0.010326:0.005125:0.009827:0.004188:0.004762:0.004551:0.009827:0.009782:0.009827:0.010311:0.005125:0.009903:0.004551:0.005866:0.004188:0.004188:0.004762:0.011188:0.004188:0.004762:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004188:0.004762:0.003024:0.009223:0.004188:0.004762:0.010175:0.004551:0.009903:0.012564:0.005125:0.009223:0.004188:0.004762:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.004188
such as neurotrophin,  including brain-derived neuro-:@0.519040:0.141723:0.923807:0.141723:0.923807:0.125940:0.519040:0.125940:0.005866:0.009192:0.009782:0.009223:0.008557:0.010326:0.005866:0.008557:0.009223:0.009827:0.009192:0.004551:0.009888:0.005125:0.004551:0.009903:0.010311:0.009223:0.003024:0.009223:0.004188:0.004188:0.004354:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.003024:0.009223:0.010175:0.008557:0.010311:0.004551:0.010326:0.003024:0.009223:0.005020:0.010357:0.009827:0.004551:0.003024:0.008376:0.009827:0.010357:0.008557:0.009223:0.009827:0.009192:0.004551:0.009903:0.005020
tropin and TGF b2, causes increased apoptosis. Tumour :@0.519040:0.155935:0.928010:0.155935:0.928010:0.140153:0.519040:0.140153:0.005125:0.004551:0.009903:0.010311:0.003024:0.009223:0.004415:0.010326:0.009223:0.010357:0.004430:0.006441:0.013184:0.007333:0.004415:0.010311:0.008376:0.004188:0.004430:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.004430:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004430:0.010326:0.010311:0.009903:0.010311:0.005125:0.009903:0.005866:0.003024:0.005866:0.004188:0.004430:0.006441:0.009192:0.014182:0.009903:0.009192:0.004551:0.004188
necrosis factor A (TNF A) in astrocytes leads to increases :@0.519040:0.170148:0.927965:0.170148:0.927965:0.154365:0.519040:0.154365:0.009223:0.009827:0.009782:0.004551:0.009903:0.005866:0.003024:0.005866:0.003810:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.003810:0.011188:0.003810:0.005579:0.006441:0.011188:0.007333:0.003810:0.011188:0.005579:0.003810:0.003024:0.009223:0.003825:0.010326:0.005866:0.005125:0.004551:0.009903:0.009782:0.008104:0.005125:0.009827:0.005866:0.003810:0.003024:0.009827:0.010326:0.010357:0.005866:0.003825:0.005125:0.009903:0.003810:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005866:0.004188
in cell death if its levels increase by direct destruction, as :@0.519040:0.184360:0.927995:0.184360:0.927995:0.168577:0.519040:0.168577:0.003024:0.009223:0.003447:0.009782:0.009827:0.003024:0.003024:0.003447:0.010357:0.009827:0.010326:0.005125:0.009223:0.003432:0.003024:0.004747:0.003447:0.003024:0.005125:0.005866:0.003447:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.003447:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.003432:0.010311:0.008104:0.003447:0.010357:0.003024:0.004551:0.009827:0.009782:0.005125:0.003432:0.010357:0.009827:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003432:0.010326:0.005866:0.004188
well as by an increase in nitric oxide synthase-2.:@0.519040:0.198572:0.866053:0.198572:0.866053:0.182790:0.519040:0.182790:0.012564:0.009827:0.003024:0.003024:0.004188:0.010326:0.005866:0.004188:0.010311:0.008104:0.004188:0.010326:0.009223:0.004188:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.004188:0.003024:0.009223:0.004188:0.009223:0.003024:0.005125:0.004551:0.003024:0.009782:0.004188:0.009903:0.007257:0.003024:0.010357:0.009827:0.004188:0.005866:0.008104:0.009223:0.005125:0.009223:0.010326:0.005866:0.009827:0.005020:0.008376:0.004188
Factor  4: :@0.533328:0.212785:0.603677:0.212785:0.603677:0.197002:0.533328:0.197002:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.004188:0.002389:0.008376:0.004188:0.004188
Vascular  insufficiency:@0.606081:0.212785:0.768157:0.212785:0.768157:0.196286:0.606081:0.196286:0.010583:0.009979:0.006652:0.009676:0.009071:0.003629:0.009979:0.004838:0.004233:0.002434:0.003629:0.009071:0.006652:0.009071:0.004233:0.003931:0.003931:0.009676:0.003629:0.009676:0.009056:0.009676:0.008769
 and glaucoma.  Cir-:@0.768157:0.212785:0.923807:0.212785:0.923807:0.197002:0.768157:0.197002:0.006592:0.010326:0.009223:0.010357:0.006592:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188:0.002389:0.012292:0.003024:0.004551:0.005020
cumstantial evidence suggests a link as people with :@0.519040:0.226997:0.927995:0.226997:0.927995:0.211215:0.519040:0.211215:0.009782:0.009192:0.014182:0.005866:0.005125:0.010326:0.009223:0.005125:0.003024:0.010326:0.003024:0.007817:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.007817:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.005866:0.007817:0.010326:0.007817:0.003024:0.003024:0.009223:0.007590:0.007817:0.010326:0.005866:0.007817:0.010311:0.009827:0.009903:0.010311:0.003024:0.009827:0.007817:0.012564:0.003024:0.005125:0.009223:0.004188
migraine and peripheral vascular abnormalities have :@0.519040:0.241210:0.927995:0.241210:0.927995:0.225427:0.519040:0.225427:0.014182:0.003024:0.010175:0.004551:0.010326:0.003024:0.009223:0.009827:0.007529:0.010326:0.009223:0.010357:0.007529:0.010311:0.009827:0.004551:0.003024:0.010311:0.009223:0.009827:0.004551:0.010326:0.003024:0.007529:0.008376:0.010326:0.005866:0.009782:0.009192:0.003024:0.010326:0.004551:0.007529:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.007529:0.009223:0.010326:0.008376:0.009827:0.004188
a higher  rate  of  glaucoma.  The  mechanisms are  not :@0.519040:0.255422:0.927980:0.255422:0.927980:0.239640:0.519040:0.239640:0.010326:0.007121:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004188:0.002918:0.004551:0.010326:0.005125:0.009827:0.004188:0.002918:0.009903:0.004747:0.004188:0.002918:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.004188:0.002918:0.006441:0.009223:0.009827:0.004188:0.002918:0.014182:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.005866:0.014182:0.005866:0.007121:0.010326:0.004551:0.009827:0.004188:0.002918:0.009223:0.009903:0.005125:0.004188
clearly understood.:@0.519040:0.269635:0.660358:0.269635:0.660358:0.253852:0.519040:0.253852:0.009782:0.003024:0.009827:0.010326:0.004551:0.003024:0.008104:0.004188:0.009192:0.009223:0.010357:0.009827:0.004551:0.005866:0.005125:0.009903:0.009903:0.010357:0.004188
Factor 5: :@0.533328:0.283847:0.603148:0.283847:0.603148:0.268065:0.533328:0.268065:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.006048:0.008376:0.004188:0.004188
Glutamate:@0.605022:0.283847:0.683339:0.283847:0.683339:0.267349:0.605022:0.267349:0.012700:0.003629:0.009071:0.004536:0.009979:0.014212:0.009979:0.004536:0.009676
-mediated toxicity has been im-:@0.683339:0.283847:0.923807:0.283847:0.923807:0.268065:0.683339:0.268065:0.005020:0.014182:0.009827:0.010357:0.003024:0.010326:0.005125:0.009827:0.010357:0.006063:0.005125:0.009903:0.007257:0.003024:0.009782:0.003024:0.005125:0.008104:0.006063:0.009223:0.010326:0.005866:0.006063:0.010311:0.009827:0.009827:0.009223:0.006063:0.003024:0.014182:0.005020
plicated in apoptosis. To maintain the physiological :@0.519040:0.298060:0.927980:0.298060:0.927980:0.282277:0.519040:0.282277:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.009207:0.003024:0.009223:0.009207:0.010326:0.010311:0.009903:0.010311:0.005125:0.009903:0.005866:0.003024:0.005866:0.004188:0.009207:0.006441:0.009903:0.009207:0.014182:0.010326:0.003024:0.009223:0.005125:0.010326:0.003024:0.009223:0.009207:0.005125:0.009223:0.009827:0.009207:0.010311:0.009223:0.008104:0.005866:0.003024:0.009903:0.003024:0.009903:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188
concentrations  and to protect  retinal ganglion cells, :@0.519040:0.312272:0.927965:0.312272:0.927965:0.296489:0.519040:0.296489:0.009782:0.009903:0.009223:0.009782:0.009827:0.009223:0.005125:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.003870:0.010326:0.009223:0.010357:0.008074:0.005125:0.009903:0.008074:0.010311:0.004551:0.009903:0.005125:0.009827:0.009782:0.005125:0.004188:0.003870:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.008074:0.010175:0.010326:0.009223:0.010175:0.003024:0.003024:0.009903:0.009223:0.008074:0.009782:0.009827:0.003024:0.003024:0.005866:0.004188:0.004188
appropriate removal of synaptic glutamate is required. :@0.519040:0.326484:0.927995:0.326484:0.927995:0.310702:0.519040:0.310702:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.004596:0.004551:0.009827:0.014182:0.009903:0.008376:0.010326:0.003024:0.004596:0.009903:0.004747:0.004596:0.005866:0.008104:0.009223:0.010326:0.010311:0.005125:0.003024:0.009782:0.004596:0.010175:0.003024:0.009192:0.005125:0.010326:0.014182:0.010326:0.005125:0.009827:0.004596:0.003024:0.005866:0.004596:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.010357:0.004188:0.004188
Muller cells and astrocytes move glutamate intracellu-:@0.519040:0.340697:0.923822:0.340697:0.923822:0.324914:0.519040:0.324914:0.013894:0.009192:0.003024:0.003024:0.009827:0.004551:0.005609:0.009782:0.009827:0.003024:0.003024:0.005866:0.005609:0.010326:0.009223:0.010357:0.005609:0.010326:0.005866:0.005125:0.004551:0.009903:0.009782:0.008104:0.005125:0.009827:0.005866:0.005609:0.014182:0.009903:0.008376:0.009827:0.005609:0.010175:0.003024:0.009192:0.005125:0.010326:0.014182:0.010326:0.005125:0.009827:0.005609:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.009827:0.003024:0.003024:0.009192:0.005020
larly where it is converted to non-toxic glutamine.:@0.519040:0.354909:0.879161:0.354909:0.879161:0.339127:0.519040:0.339127:0.003024:0.010326:0.004551:0.003024:0.008104:0.004188:0.012564:0.009223:0.009827:0.004551:0.009827:0.004188:0.003024:0.005125:0.004188:0.003024:0.005866:0.004188:0.009782:0.009903:0.009223:0.008376:0.009827:0.004551:0.005125:0.009827:0.010357:0.004188:0.005125:0.009903:0.004188:0.009223:0.009903:0.009223:0.005020:0.005125:0.009903:0.007257:0.003024:0.009782:0.004188:0.010175:0.003024:0.009192:0.005125:0.010326:0.014182:0.003024:0.009223:0.009827:0.004188
Factor 6: Increased :@0.533328:0.369122:0.678849:0.369122:0.678849:0.353339:0.533328:0.353339:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.004279:0.008376:0.004188:0.004294:0.003417:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.004188
nitric oxide:@0.678954:0.369122:0.760083:0.369122:0.760083:0.352623:0.678954:0.352623:0.009071:0.003629:0.004536:0.004838:0.003629:0.009676:0.004324:0.009676:0.008467:0.003629:0.009979:0.009676
 has been linked to an :@0.760083:0.369122:0.927965:0.369122:0.927965:0.353339:0.760083:0.353339:0.004294:0.009223:0.010326:0.005866:0.004294:0.010311:0.009827:0.009827:0.009223:0.004294:0.003024:0.003024:0.009223:0.007590:0.009827:0.010357:0.004294:0.005125:0.009903:0.004294:0.010326:0.009223:0.004188
increased incidence of glaucoma. The nitric oxide dif-:@0.519040:0.383334:0.923792:0.383334:0.923792:0.367552:0.519040:0.367552:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.010357:0.005488:0.003024:0.009223:0.009782:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005488:0.009903:0.004747:0.005488:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004188:0.005488:0.006441:0.009223:0.009827:0.005488:0.009223:0.003024:0.005125:0.004551:0.003024:0.009782:0.005488:0.009903:0.007257:0.003024:0.010357:0.009827:0.005488:0.010357:0.003024:0.004747:0.005020
fuses intracellularly where  it produces  highly reactive :@0.519040:0.397547:0.927995:0.397547:0.927995:0.381764:0.519040:0.381764:0.004747:0.009192:0.005866:0.009827:0.005866:0.007605:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.009827:0.003024:0.003024:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.007605:0.012564:0.009223:0.009827:0.004551:0.009827:0.004188:0.003402:0.003024:0.005125:0.007605:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.009827:0.005866:0.004188:0.003402:0.009223:0.003024:0.010175:0.009223:0.003024:0.008104:0.007605:0.004551:0.009827:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188
free radicals that cause massive cell destruction.:@0.519040:0.411759:0.874459:0.411759:0.874459:0.395977:0.519040:0.395977:0.004747:0.004551:0.009827:0.009827:0.004188:0.004551:0.010326:0.010357:0.003024:0.009782:0.010326:0.003024:0.005866:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.009782:0.010326:0.009192:0.005866:0.009827:0.004188:0.014182:0.010326:0.005866:0.005866:0.003024:0.008376:0.009827:0.004188:0.009782:0.009827:0.003024:0.003024:0.004188:0.010357:0.009827:0.005866:0.005125:0.004551:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188
Factor 7: :@0.533328:0.425972:0.600562:0.425972:0.600562:0.410189:0.533328:0.410189:0.007333:0.010326:0.009782:0.005125:0.009903:0.004551:0.003462:0.008376:0.004188:0.004188
Oxidative stress:@0.599837:0.425972:0.713411:0.425972:0.713411:0.409473:0.599837:0.409473:0.012700:0.008467:0.003629:0.009979:0.009979:0.004536:0.003629:0.008467:0.009676:0.003508:0.006652:0.004536:0.004838:0.009676:0.006652:0.006652
 and free radicals have been :@0.713411:0.425972:0.927980:0.425972:0.927980:0.410189:0.713411:0.410189:0.003462:0.010326:0.009223:0.010357:0.003462:0.004747:0.004551:0.009827:0.009827:0.003462:0.004551:0.010326:0.010357:0.003024:0.009782:0.010326:0.003024:0.005866:0.003477:0.009223:0.010326:0.008376:0.009827:0.003462:0.010311:0.009827:0.009827:0.009223:0.004188
shown to play an aetio-pathogenic role in retinal gan-:@0.519040:0.440184:0.923807:0.440184:0.923807:0.424401:0.519040:0.424401:0.005866:0.009223:0.009903:0.012564:0.009223:0.005261:0.005125:0.009903:0.005261:0.010311:0.003024:0.010326:0.008104:0.005277:0.010326:0.009223:0.005261:0.010326:0.009827:0.005125:0.003024:0.009903:0.005020:0.010311:0.010326:0.005125:0.009223:0.009903:0.010175:0.009827:0.009223:0.003024:0.009782:0.005261:0.004551:0.009903:0.003024:0.009827:0.005261:0.003024:0.009223:0.005261:0.004551:0.009827:0.005125:0.003024:0.009223:0.010326:0.003024:0.005261:0.010175:0.010326:0.009223:0.005020
glion cell death.:@0.519040:0.454397:0.637468:0.454397:0.637468:0.438614:0.519040:0.438614:0.010175:0.003024:0.003024:0.009903:0.009223:0.004188:0.009782:0.009827:0.003024:0.003024:0.004188:0.010357:0.009827:0.010326:0.005125:0.009223:0.004188
GenetiCs Of GlAuCOmA:@0.519047:0.487553:0.748554:0.487553:0.748554:0.467388:0.519047:0.467388:0.015522:0.009609:0.013674:0.009609:0.007761:0.005174:0.014413:0.009609:0.005174:0.015522:0.008870:0.005174:0.015522:0.008131:0.013674:0.011826:0.014413:0.015522:0.016631:0.013674
9:@0.748508:0.481077:0.754510:0.481077:0.754510:0.469381:0.748508:0.469381:0.006002
several genes have been implicated in glaucoma with :@0.519047:0.503548:0.928017:0.503548:0.928017:0.487766:0.519047:0.487766:0.007378:0.009676:0.008225:0.009676:0.004400:0.010175:0.002873:0.005413:0.010024:0.009676:0.009071:0.009676:0.005715:0.005413:0.009071:0.010175:0.008225:0.009676:0.005413:0.010160:0.009676:0.009676:0.009071:0.005413:0.002873:0.014030:0.010160:0.002873:0.002873:0.009631:0.010175:0.004974:0.009676:0.010205:0.005413:0.002873:0.009071:0.005413:0.010024:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.005413:0.012413:0.002873:0.004974:0.009223:0.004188
a monogenic, autosomal dominant trait. This, however, :@0.519047:0.517761:0.927987:0.517761:0.927987:0.501978:0.519047:0.501978:0.010175:0.005534:0.014030:0.009752:0.009071:0.009752:0.010024:0.009676:0.009071:0.002873:0.009631:0.004037:0.005534:0.010175:0.009041:0.004974:0.009752:0.005715:0.009752:0.014030:0.010175:0.002873:0.005534:0.010205:0.009752:0.014030:0.002873:0.009071:0.010175:0.009071:0.004974:0.005534:0.004974:0.004400:0.010175:0.002873:0.004974:0.004037:0.005534:0.006290:0.009071:0.002873:0.005715:0.004037:0.005534:0.009071:0.009752:0.012413:0.009676:0.008225:0.009676:0.004400:0.004188:0.004188
accounts for only 10% of all glaucoma. The first reported :@0.519047:0.531973:0.927972:0.531973:0.927972:0.516191:0.519047:0.516191:0.010175:0.009631:0.009631:0.009752:0.009041:0.009071:0.004974:0.005715:0.004400:0.004596:0.009752:0.004400:0.004400:0.009752:0.009071:0.002873:0.007953:0.004400:0.008225:0.008225:0.011566:0.004400:0.009752:0.004596:0.004400:0.010175:0.002873:0.002873:0.004400:0.010024:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.004037:0.004400:0.006290:0.009071:0.009676:0.004400:0.003606:0.003606:0.004400:0.005715:0.004974:0.004400:0.004400:0.009676:0.010160:0.009752:0.004400:0.004974:0.009676:0.010357:0.004188
locus for primary open-angle glaucoma was located on :@0.519047:0.546186:0.928017:0.546186:0.928017:0.530403:0.519047:0.530403:0.002873:0.009752:0.009631:0.009041:0.005715:0.004203:0.004596:0.009752:0.004400:0.004203:0.010160:0.004400:0.002873:0.014030:0.010175:0.004400:0.007953:0.004203:0.009752:0.010160:0.009676:0.009071:0.004868:0.010175:0.009071:0.010024:0.002873:0.009676:0.004203:0.010024:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.004203:0.012413:0.010175:0.005715:0.004203:0.002873:0.009752:0.009631:0.010175:0.004974:0.009676:0.010205:0.004203:0.009752:0.009223:0.004188
chromosome 1 (GLC1A). The gene encoding for myocilin :@0.519047:0.560398:0.928032:0.560398:0.928032:0.544616:0.519047:0.544616:0.009631:0.009071:0.004400:0.009752:0.014030:0.009752:0.005715:0.009752:0.014030:0.009676:0.003266:0.008225:0.003266:0.005428:0.013033:0.006834:0.012141:0.008225:0.011037:0.005428:0.004037:0.003266:0.006290:0.009071:0.009676:0.003266:0.010024:0.009676:0.009071:0.009676:0.003266:0.009676:0.009071:0.009631:0.009752:0.010205:0.002873:0.009071:0.010024:0.003266:0.004596:0.009752:0.004400:0.003266:0.014030:0.007953:0.009752:0.009631:0.002873:0.002873:0.002873:0.009223:0.004188
(MYOC ) is located at that locus. Myocilin mutations are :@0.519047:0.574611:0.928032:0.574611:0.928032:0.558828:0.519047:0.558828:0.005428:0.013743:0.008799:0.012987:0.012141:0.004581:0.005428:0.004581:0.002873:0.005715:0.004581:0.002873:0.009752:0.009631:0.010175:0.004974:0.009676:0.010205:0.004581:0.010175:0.004974:0.004581:0.004974:0.009071:0.010175:0.004974:0.004581:0.002873:0.009752:0.009631:0.009041:0.005715:0.004037:0.004581:0.013743:0.007953:0.009752:0.009631:0.002873:0.002873:0.002873:0.009071:0.004581:0.014030:0.009041:0.004974:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004581:0.010175:0.004400:0.009827:0.004188
found in juvenile and early adult pOAG with very high in-:@0.519047:0.588823:0.923769:0.588823:0.923769:0.573040:0.519047:0.573040:0.004596:0.009752:0.009041:0.009071:0.010205:0.004052:0.002873:0.009071:0.004052:0.002918:0.009041:0.008225:0.009676:0.009071:0.002873:0.002873:0.009676:0.004052:0.010175:0.009071:0.010205:0.004052:0.009676:0.010175:0.004400:0.002873:0.007953:0.004052:0.010175:0.010205:0.009041:0.002873:0.004974:0.004052:0.008799:0.012987:0.011037:0.013033:0.004052:0.012413:0.002873:0.004974:0.009071:0.004052:0.008225:0.009676:0.004400:0.007953:0.004052:0.009071:0.002873:0.010024:0.009071:0.004052:0.002873:0.009071:0.005020
tra-ocular pressures. Individuals with the optineurin gene :@0.519047:0.603036:0.927972:0.603036:0.927972:0.587253:0.519047:0.587253:0.004974:0.004400:0.010175:0.004868:0.009752:0.009631:0.009041:0.002873:0.010175:0.004400:0.004642:0.010160:0.004400:0.009676:0.005715:0.005715:0.009041:0.004400:0.009676:0.005715:0.004037:0.004642:0.003266:0.009071:0.010205:0.002873:0.008225:0.002873:0.010205:0.009041:0.010175:0.002873:0.005715:0.004642:0.012413:0.002873:0.004974:0.009071:0.004642:0.004974:0.009071:0.009676:0.004642:0.009752:0.010160:0.004974:0.002873:0.009071:0.009676:0.009041:0.004400:0.002873:0.009071:0.004642:0.010024:0.009676:0.009071:0.009827:0.004188
(OpTN, GLC1E) variations have normal intra-ocular pres-:@0.519047:0.617248:0.923784:0.617248:0.923784:0.601465:0.519047:0.601465:0.005428:0.012987:0.008799:0.006290:0.011037:0.004037:0.004944:0.013033:0.006834:0.012141:0.008225:0.007953:0.005428:0.004944:0.008225:0.010175:0.004400:0.002873:0.010175:0.004974:0.002873:0.009752:0.009071:0.005715:0.004944:0.009071:0.010175:0.008225:0.009676:0.004944:0.009071:0.009752:0.004400:0.014030:0.010175:0.002873:0.004944:0.002873:0.009071:0.004974:0.004400:0.010175:0.004868:0.009752:0.009631:0.009041:0.002873:0.010175:0.004400:0.004944:0.010160:0.004400:0.009676:0.005715:0.005020
sure. Optineurin may have a neuroprotective effect.:@0.519047:0.631460:0.894362:0.631460:0.894362:0.615678:0.519047:0.615678:0.005715:0.009041:0.004400:0.009676:0.004037:0.004037:0.012987:0.010160:0.004974:0.002873:0.009071:0.009676:0.009041:0.004400:0.002873:0.009071:0.004037:0.014030:0.010175:0.007953:0.004037:0.009071:0.010175:0.008225:0.009676:0.004037:0.010175:0.004037:0.009071:0.009676:0.009041:0.004400:0.009752:0.010160:0.004400:0.009752:0.004974:0.009676:0.009631:0.004974:0.002873:0.008225:0.009676:0.004037:0.009676:0.004596:0.004596:0.009676:0.009631:0.004974:0.004188
The CAV1/CAV2 (HGNC:1527/HGNC: 1528) locus on :@0.533335:0.645673:0.927987:0.645673:0.927987:0.629890:0.533335:0.629890:0.006441:0.009223:0.009827:0.005866:0.012292:0.011188:0.010614:0.008376:0.006607:0.012292:0.011188:0.010614:0.008376:0.005881:0.005579:0.010326:0.013184:0.011188:0.012292:0.004188:0.008376:0.008376:0.008376:0.008376:0.006607:0.010326:0.013184:0.011188:0.012292:0.004188:0.005881:0.008376:0.008376:0.008376:0.008376:0.005579:0.005896:0.003024:0.009903:0.009782:0.009192:0.005866:0.005881:0.009903:0.009223:0.004188
7q34 may be associated with pOAG in European popu-:@0.519047:0.659885:0.923799:0.659885:0.923799:0.644103:0.519047:0.644103:0.008376:0.010311:0.008376:0.008376:0.003931:0.014182:0.010326:0.008104:0.003916:0.010311:0.009827:0.003916:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.003916:0.012564:0.003024:0.005125:0.009223:0.003916:0.008950:0.013138:0.011188:0.013184:0.003916:0.003024:0.009223:0.003916:0.008104:0.009192:0.004551:0.009903:0.010311:0.009827:0.010326:0.009223:0.003916:0.010311:0.009903:0.010311:0.009192:0.005020
lations. The CDKN2BAs (HGNC:34341) locus on 9p21 has :@0.519047:0.674098:0.927987:0.674098:0.927987:0.658315:0.519047:0.658315:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.003886:0.006441:0.009223:0.009827:0.003870:0.012292:0.011249:0.008935:0.011188:0.008376:0.008678:0.011188:0.007529:0.003886:0.005579:0.010326:0.013184:0.011188:0.012292:0.004188:0.008376:0.008376:0.008376:0.008376:0.008376:0.005579:0.003901:0.003024:0.009903:0.009782:0.009192:0.005866:0.003886:0.009903:0.009223:0.003870:0.008376:0.010311:0.008376:0.008376:0.003886:0.009223:0.010326:0.005866:0.004188
also been shown to  be associated with glaucoma in :@0.519047:0.688310:0.928002:0.688310:0.928002:0.672528:0.519047:0.672528:0.010326:0.003024:0.005866:0.009903:0.006879:0.010311:0.009827:0.009827:0.009223:0.006879:0.005866:0.009223:0.009903:0.012564:0.009223:0.006879:0.005125:0.009903:0.004188:0.002676:0.010311:0.009827:0.006879:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.006879:0.012564:0.003024:0.005125:0.009223:0.006879:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.006879:0.003024:0.009223:0.004188
multiple cohorts.:@0.519047:0.702523:0.639486:0.702523:0.639486:0.686740:0.519047:0.686740:0.014182:0.009192:0.003024:0.005125:0.003024:0.010311:0.003024:0.009827:0.004188:0.009782:0.009903:0.009223:0.009903:0.004551:0.005125:0.005866:0.004188
treAtment OPtiOns:@0.519047:0.735559:0.699031:0.735559:0.699031:0.715394:0.519047:0.715394:0.007761:0.010718:0.009609:0.013674:0.007761:0.016631:0.009609:0.013674:0.007761:0.005174:0.015522:0.010348:0.007761:0.005174:0.015522:0.013674:0.009609
medical:@0.519047:0.758363:0.585907:0.758363:0.585907:0.740031:0.519047:0.740031:0.015119:0.010751:0.011087:0.004032:0.010751:0.011087:0.004032
There are five classes of drugs available to lower intra-:@0.519047:0.774752:0.923799:0.774752:0.923799:0.758969:0.519047:0.758969:0.006441:0.009223:0.009827:0.004551:0.009827:0.005382:0.010326:0.004551:0.009827:0.005382:0.003681:0.003681:0.008376:0.009827:0.005397:0.009782:0.003024:0.010326:0.005866:0.005866:0.009827:0.005866:0.005397:0.009903:0.004747:0.005397:0.010357:0.004551:0.009192:0.010175:0.005866:0.005397:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.005413:0.005125:0.009903:0.005382:0.003024:0.009903:0.012564:0.009827:0.004551:0.005382:0.003024:0.009223:0.005125:0.004551:0.010326:0.005020
ocular pressure. Medical management is usually the first :@0.519047:0.788964:0.928002:0.788964:0.928002:0.773182:0.519047:0.773182:0.009903:0.009782:0.009192:0.003024:0.010326:0.004551:0.003780:0.010311:0.004551:0.009827:0.005866:0.005866:0.009192:0.004551:0.009827:0.004188:0.003780:0.013894:0.009827:0.010357:0.003024:0.009782:0.010326:0.003024:0.003780:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.003765:0.003024:0.005866:0.003780:0.009192:0.005866:0.009192:0.010326:0.003024:0.003024:0.008104:0.003795:0.005125:0.009223:0.009827:0.003780:0.003681:0.003681:0.004551:0.005866:0.005125:0.004188
line of treatment (see Table 1). Unfortunately, the medi-:@0.519047:0.803177:0.923799:0.803177:0.923799:0.787394:0.519047:0.787394:0.003024:0.003024:0.009223:0.009827:0.004188:0.009903:0.004747:0.004188:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004173:0.005579:0.005866:0.009827:0.009827:0.004188:0.006441:0.010326:0.010311:0.003024:0.009827:0.004188:0.008376:0.005579:0.004188:0.004188:0.009903:0.009223:0.004747:0.009903:0.004551:0.005125:0.009192:0.009223:0.010326:0.005125:0.009827:0.003024:0.008104:0.004188:0.004173:0.005125:0.009223:0.009827:0.004188:0.014182:0.009827:0.010357:0.003024:0.005020
cation alters the conjunctiva and can have detrimental :@0.519047:0.817389:0.928002:0.817389:0.928002:0.801607:0.519047:0.801607:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.003689:0.010326:0.003024:0.005125:0.009827:0.004551:0.005866:0.003704:0.005125:0.009223:0.009827:0.003689:0.009782:0.009903:0.009223:0.003069:0.009192:0.009223:0.009782:0.005125:0.003024:0.008376:0.010326:0.003689:0.010326:0.009223:0.010357:0.003704:0.009782:0.010326:0.009223:0.003704:0.009223:0.010326:0.008376:0.009827:0.003704:0.010357:0.009827:0.005125:0.004551:0.003024:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.004188
effects on doing glaucoma surgery. some medications :@0.519047:0.831602:0.927987:0.831602:0.927987:0.815819:0.519047:0.815819:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004596:0.009903:0.009223:0.004596:0.010357:0.009903:0.003024:0.009223:0.010175:0.004596:0.010175:0.003024:0.010326:0.009192:0.009782:0.009903:0.014182:0.010326:0.004596:0.005866:0.009192:0.004551:0.010175:0.009827:0.004551:0.008104:0.004188:0.004596:0.007529:0.009903:0.014182:0.009827:0.004596:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
need to be refrigerated, which can be difficult for pa:@0.519047:0.845814:0.918810:0.845814:0.918810:0.830032:0.519047:0.830032:0.009223:0.009827:0.009827:0.010357:0.005397:0.005125:0.009903:0.005397:0.010311:0.009827:0.005397:0.004551:0.009827:0.004747:0.004551:0.003024:0.010175:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004188:0.005382:0.012564:0.009223:0.003024:0.009782:0.009223:0.005397:0.009782:0.010326:0.009223:0.005397:0.010311:0.009827:0.005397:0.010357:0.003024:0.004747:0.003681:0.003681:0.009782:0.009192:0.003024:0.005125:0.005397:0.004747:0.009903:0.004551:0.005382:0.010311:0.010326
-:@0.918810:0.845814:0.923829:0.845814:0.923829:0.830032:0.918810:0.830032:0.005020
tients who do not have access to refrigeration or to sol-:@0.519047:0.860027:0.923814:0.860027:0.923814:0.844244:0.519047:0.844244:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004400:0.012564:0.009223:0.009903:0.004400:0.010357:0.009903:0.004400:0.009223:0.009903:0.005125:0.004400:0.009223:0.010326:0.008376:0.009827:0.004400:0.010326:0.009782:0.009782:0.009827:0.005866:0.005866:0.004415:0.005125:0.009903:0.004400:0.004551:0.009827:0.004747:0.004551:0.003024:0.010175:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004385:0.009903:0.004551:0.004400:0.005125:0.009903:0.004400:0.005866:0.009903:0.003024:0.005020
diers who have been deployed. All medications have :@0.519047:0.874239:0.927972:0.874239:0.927972:0.858456:0.519047:0.858456:0.010357:0.003024:0.009827:0.004551:0.005866:0.005851:0.012564:0.009223:0.009903:0.005851:0.009223:0.010326:0.008376:0.009827:0.005851:0.010311:0.009827:0.009827:0.009223:0.005851:0.010357:0.009827:0.010311:0.003024:0.009903:0.008104:0.009827:0.010357:0.004188:0.005851:0.011188:0.003024:0.003024:0.005851:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.005851:0.009223:0.010326:0.008376:0.009827:0.004188
side effects to a degree, and the benefits of the medi:@0.519047:0.888451:0.918810:0.888451:0.918810:0.872669:0.519047:0.872669:0.005866:0.003024:0.010357:0.009827:0.004883:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004883:0.005125:0.009903:0.004883:0.010326:0.004883:0.010357:0.009827:0.010175:0.004551:0.009827:0.009827:0.004188:0.004868:0.010326:0.009223:0.010357:0.004883:0.005125:0.009223:0.009827:0.004883:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.004883:0.009903:0.004747:0.004883:0.005125:0.009223:0.009827:0.004883:0.014182:0.009827:0.010357:0.003024
-:@0.918810:0.888451:0.923829:0.888451:0.923829:0.872669:0.918810:0.872669:0.005020
cation :@0.519047:0.902664:0.570618:0.902664:0.570618:0.886881:0.519047:0.886881:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
versus:@0.570513:0.902664:0.614191:0.902664:0.614191:0.886881:0.570513:0.886881:0.008376:0.009827:0.004551:0.005866:0.009192:0.005866
 the side-effect profile should be discussed :@0.614191:0.902664:0.928002:0.902664:0.928002:0.886881:0.614191:0.886881:0.004082:0.005125:0.009223:0.009827:0.004082:0.005866:0.003024:0.010357:0.009827:0.005020:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.004082:0.010311:0.004551:0.009903:0.003681:0.003681:0.003024:0.009827:0.004067:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004082:0.010311:0.009827:0.004082:0.010357:0.003024:0.005866:0.009782:0.009192:0.005866:0.005866:0.009827:0.010357:0.004188
and monitored for each patient, and treatment modi-:@0.519047:0.916876:0.923799:0.916876:0.923799:0.901094:0.519047:0.901094:0.010326:0.009223:0.010357:0.005367:0.014182:0.009903:0.009223:0.003024:0.005125:0.009903:0.004551:0.009827:0.010357:0.005352:0.004747:0.009903:0.004551:0.005367:0.009827:0.010326:0.009782:0.009223:0.005367:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188:0.005367:0.010326:0.009223:0.010357:0.005367:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005352:0.014182:0.009903:0.010357:0.003024:0.005020
fied accordingly. Access to medicine is also a problem :@0.519047:0.931089:0.927987:0.931089:0.927987:0.915306:0.519047:0.915306:0.003681:0.003681:0.009827:0.010357:0.004717:0.010326:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.003024:0.008104:0.004188:0.004717:0.011188:0.009782:0.009782:0.009827:0.005866:0.005866:0.004717:0.005125:0.009903:0.004717:0.014182:0.009827:0.010357:0.003024:0.009782:0.003024:0.009223:0.009827:0.004717:0.003024:0.005866:0.004717:0.010326:0.003024:0.005866:0.009903:0.004717:0.010326:0.004717:0.010311:0.004551:0.009903:0.010311:0.003024:0.009827:0.014182:0.004188
in certain settings, and one of the appropriate surgical :@0.519047:0.945301:0.927987:0.945301:0.927987:0.929519:0.519047:0.929519:0.003024:0.009223:0.005004:0.009782:0.009827:0.004551:0.005125:0.010326:0.003024:0.009223:0.005004:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.005866:0.004188:0.005004:0.010326:0.009223:0.010357:0.005004:0.009903:0.009223:0.009827:0.005004:0.009903:0.004747:0.005004:0.005125:0.009223:0.009827:0.005004:0.010326:0.010311:0.010311:0.004551:0.009903:0.010311:0.004551:0.003024:0.010326:0.005125:0.009827:0.005004:0.005866:0.009192:0.004551:0.010175:0.003024:0.009782:0.010326:0.003024:0.004188